Tango Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Highlights

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. QCOM
2. CBRS
3. FDX
4. USO
5. MU
6. SPY
7. KBH
8. HTZ
9. HON
10. JPM

Go back to Tango Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Highlights

Tango Therapeutics, Inc. (TNGX) Misses Q3 EPS by 7c

November 4, 2025 9:04 AM EST

Tango Therapeutics, Inc. (NASDAQ: TNGX) reported Q3 EPS of ($0.14), $0.07 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $53.81 million versus the consensus estimate of $53.8 million.

For earnings history and earnings-related data on Tango Therapeutics, Inc. (TNGX) click here.

... More